BIO Submits Comments on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses Proposed Rule
BIO submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the proposed rule, Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses Proposed Rule.
BIO is extremely concerned the Agency continues to erode the value of the Medicare benefit for seniors, placing patient access at risk. This proposed rule prioritizes cost containment policies over patient healthcare needs. BIO respectfully requests the Agency and Administration instead focus on holistic solutions to balance the financial sustainability of the Medicare program, while addressing patient out-of-pocket cost and access to appropriate treatment. In the comments, BIO provides specific recommendations for how CMS can improve the proposed rule and ensure greater access for patients while directly reducing OOP costs.